The CoLab is being launched over the backdrop of the Covid-19 global pandemic created an urgent need for timely access to therapeutics and diagnostics with telemedicine and telesurgery are more important than ever.
“As a responsible global technology leader, we are proud to contribute and support the creation of macro-scale solutions to healthcare issues for a better future for all,” said G H Rao, President, Engineering and R&D Services, HCL Technologies.
“HCL’s commitment, combined with its vision for technology innovation and its global reach, will allow us to realize the goals of the CoLab quickly,” said Daniel Fletcher, Associate Director for Research of the Blum Center, Purnendu Chatterjee Chair of Bioengineering, and Director of the CoLab.